Steven G. Kultgen

443 total citations
15 papers, 201 citations indexed

About

Steven G. Kultgen is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Steven G. Kultgen has authored 15 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Steven G. Kultgen's work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Chemical Synthesis and Analysis (3 papers). Steven G. Kultgen is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Chemical Synthesis and Analysis (3 papers). Steven G. Kultgen collaborates with scholars based in United States and United Kingdom. Steven G. Kultgen's co-authors include Koc-Kan Ho, Jason M. Foulks, Edward McDonald, Steven B. Kanner, Tao Guo, Maria L. Webb, Michael V. McCullar, Anton E.P. Adang, Nicole C.R. van Straten and Kenneth J. Valenzano and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Steven G. Kultgen

14 papers receiving 183 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven G. Kultgen United States 7 87 75 42 28 24 15 201
Matthew W. Boudreau United States 10 113 1.3× 59 0.8× 5 0.1× 22 0.8× 16 0.7× 20 266
John F. Mehlmann United States 7 68 0.8× 144 1.9× 8 0.2× 11 0.4× 26 1.1× 11 221
Dandan Huang China 11 146 1.7× 59 0.8× 1 0.0× 24 0.9× 18 0.8× 17 328
Pranavanand Nyshadham United States 9 189 2.2× 85 1.1× 8 0.2× 9 0.3× 8 0.3× 11 262
Suzannah J. Harnor United Kingdom 8 119 1.4× 27 0.4× 5 0.1× 8 0.3× 9 0.4× 12 177
Kwiwan Jeong South Korea 11 208 2.4× 32 0.4× 3 0.1× 48 1.7× 15 0.6× 21 336
Zhongren Wu United States 9 123 1.4× 24 0.3× 2 0.0× 13 0.5× 51 2.1× 14 193
Joel A. Yalowitz United States 10 220 2.5× 63 0.8× 2 0.0× 101 3.6× 10 0.4× 14 354
Jana M. Bednarek United States 7 112 1.3× 48 0.6× 2 0.0× 16 0.6× 35 1.5× 10 297
Fen Pei United States 10 127 1.5× 19 0.3× 2 0.0× 28 1.0× 4 0.2× 20 244

Countries citing papers authored by Steven G. Kultgen

Since Specialization
Citations

This map shows the geographic impact of Steven G. Kultgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven G. Kultgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven G. Kultgen more than expected).

Fields of papers citing papers by Steven G. Kultgen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven G. Kultgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven G. Kultgen. The network helps show where Steven G. Kultgen may publish in the future.

Co-authorship network of co-authors of Steven G. Kultgen

This figure shows the co-authorship network connecting the top 25 collaborators of Steven G. Kultgen. A scholar is included among the top collaborators of Steven G. Kultgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven G. Kultgen. Steven G. Kultgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mesaros, Eugen F., Andrew G. Cole, Steven G. Kultgen, et al.. (2024). Conformationally Constrained Isoquinolinones as Orally Efficacious Hepatitis B Capsid Assembly Modulators. ACS Medicinal Chemistry Letters. 15(9). 1627–1634. 2 indexed citations
2.
Cole, Andrew G., Steven G. Kultgen, Nagraj Mani, et al.. (2024). Rational Design, Synthesis, and Structure–Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836. Journal of Medicinal Chemistry. 67(18). 16773–16795. 4 indexed citations
3.
Cole, Andrew G., Steven G. Kultgen, Nagraj Mani, et al.. (2023). Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506. Bioorganic & Medicinal Chemistry Letters. 94. 129456–129456. 4 indexed citations
4.
Thi, Emily P., Andrew G. Cole, Seyma Ozturk, et al.. (2022). Preclinical activity of small-molecule oral PD-L1 checkpoint inhibitors capable of reinvigorating T cell responses from chronic hepatitis B patients. Journal of Hepatology. 77. S848–S848. 1 indexed citations
5.
Thi, Emily P., Andrew G. Cole, Seyma Ozturk, et al.. (2022). Preclinical anti-tumor activity of small-molecule oral PD-L1 checkpoint inhibitors.. Journal of Clinical Oncology. 40(16_suppl). e14558–e14558. 1 indexed citations
6.
Cole, Andrew G., Steven G. Kultgen, Nagraj Mani, et al.. (2022). The identification of highly efficacious functionalised tetrahydrocyclopenta[c]pyrroles as inhibitors of HBV viral replication through modulation of HBV capsid assembly. RSC Medicinal Chemistry. 13(3). 343–349. 6 indexed citations
7.
Liu, Fei, Amy C. H. Lee, Fang Guo, et al.. (2021). Host Poly(A) Polymerases PAPD5 and PAPD7 Provide Two Layers of Protection That Ensure the Integrity and Stability of Hepatitis B Virus RNA. Journal of Virology. 95(18). 18 indexed citations
8.
Xu, Yong, Steven G. Kultgen, Jason M. Foulks, et al.. (2014). Synthesis and Biological Evaluation of Pyrazolo[1,5-a]pyrimidine Compounds as Potent and Selective Pim-1 Inhibitors. ACS Medicinal Chemistry Letters. 6(1). 63–67. 44 indexed citations
9.
Ho, Koc-Kan, K. Mark Parnell, Yi Yuan, et al.. (2012). Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(2). 569–573. 23 indexed citations
10.
Cole, Andrew G., Steven G. Kultgen, & Ian Henderson. (2009). Microwave-Assisted, One-Pot Synthesis of 5-Thia-4b,10-diaza-indeno[2,1-a]-indene-5,5-dioxide and 10H-11-Thia-5,10a-diaza-benzo[b]fluorene-11,11-dioxide. Synthetic Communications. 39(20). 3607–3610.
11.
Guo, Tao, Anton E.P. Adang, Peng Geng, et al.. (2004). Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesis. Bioorganic & Medicinal Chemistry Letters. 14(7). 1717–1720. 38 indexed citations
12.
Guo, Tao, Anton E.P. Adang, Roland E. Dolle, et al.. (2004). Small molecule biaryl FSH receptor agonists. Part 1. Bioorganic & Medicinal Chemistry Letters. 14(7). 1713–1716. 37 indexed citations
13.
Ho, Koc-Kan, Kenneth C. Appell, John J. Baldwin, et al.. (2003). 2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(2). 545–548. 12 indexed citations
14.
Mahnke, Lisa, et al.. (2000). Aberrant SRN1 Reaction of 4-Aminophenol with α,p-Dinitrocumene:  EPR Observation of Intermediates. Organic Letters. 2(6). 827–829. 6 indexed citations
15.
Lewis, Frederick D. & Steven G. Kultgen. (1998). Photochemical synthesis of medium-ring azalactams from N-(aminoalkyl)-2-stilbenecarboxamides. Journal of Photochemistry and Photobiology A Chemistry. 112(2-3). 159–164. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026